Efficacy and Safety of Non-Racemic Amisulpride in Bipolar Depression - The Prospective Enrichment for Canonical Symptom Structure at Baseline Increased Study Power at Endpoint

被引:0
|
作者
Hopkins, Seth [1 ]
Szabo, Steven [1 ]
Corriveau, Taryn [1 ]
Tomioka, Sasagu [1 ]
Koblan, Kenneth [1 ]
机构
[1] Sumitomo Pharma Amer Inc, Marlborough, MA USA
关键词
machine learning; Bipolar I Depression; Clinical Development; inclusion and exclusion;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
P116
引用
收藏
页码:129 / 130
页数:2
相关论文
共 1 条
  • [1] A Randomized, Double-blind, Placebo-controlled Proof-of-Concept Trial to Evaluate the Efficacy and Safety of Non-racemic Amisulpride (SEP-4199) for the Treatment of Bipolar I Depression
    Loebel, Antony
    Koblan, Kenneth S.
    Tsai, Joyce
    Deng, Ling
    Fava, Maurizio
    Kent, Justine
    Hopkins, Seth C.
    JOURNAL OF AFFECTIVE DISORDERS, 2022, 296 : 549 - 558